These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12711580)

  • 1. Ask the doctor. I heard on the news that the pacemaker inside an implantable cardioverter/defibrillator (ICD) can damage the heart. Is that true?
    Lee TH
    Harv Heart Lett; 2003 Apr; 13(8):8. PubMed ID: 12711580
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventricular bigeminy as a cause of CRT inefficacy and inappropriate cardioverter-defibrillator intervention].
    Oreziak A; Przybylski A; Walczak F
    Kardiol Pol; 2009 Jul; 67(7):807-11. PubMed ID: 19650008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing with pacemakers and implantable cardioverter defibrillators.
    Lampert R
    Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardioverter-defibrillator conundrum: sometimes you turn the pacemaker off.
    SoRelle R
    Circulation; 2003 Jul; 108(2):e9002-3. PubMed ID: 12860896
    [No Abstract]   [Full Text] [Related]  

  • 12. [Annual report 2017 of the German pacemaker- and defibrillator register - Part 2: implantable cardioverter defibrillators (ICD). : Working group on Cardiac pacemaker and implantable cardioverter-defibrillators at the IQTIG - Institute of Quality Assurance and Transparency in Healthcare].
    Markewitz A;
    Herzschrittmacherther Elektrophysiol; 2019 Dec; 30(4):389-403. PubMed ID: 31705261
    [No Abstract]   [Full Text] [Related]  

  • 13. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluations: the very last chance to identify a problem with a pacemaker or implanted cardioverter-defibrillator.
    Rozner MA
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):341-6. PubMed ID: 18503919
    [No Abstract]   [Full Text] [Related]  

  • 15. Ventricular asystole during atrial antitachycardia pacing by implanted cardioverter-defibrillator.
    Herweg B; Barold SS
    Pacing Clin Electrophysiol; 2005 May; 28(5):432-3. PubMed ID: 15869677
    [No Abstract]   [Full Text] [Related]  

  • 16. There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure.
    Daubert JC; Leclercq C; Mabo P
    J Am Coll Cardiol; 2005 Dec; 46(12):2204-7. PubMed ID: 16360047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pacemaker and automated implantable defibrillator in daily care].
    Lotton P
    Soins; 2008; (722 Suppl):S3-4. PubMed ID: 18340988
    [No Abstract]   [Full Text] [Related]  

  • 19. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
    Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
    Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.